Is Fluor (FLR) Stock Outpacing Its Construction Peers This Year?
Here is how Fluor (FLR) and Legence (LGN) have performed compared to their sector so far this year.
FLR - Fluor Corporation
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$62.33
DETAILS
HIGH:
$71.00
LOW:
$50.00
MEDIAN:
$66.00
CONSENSUS:
$62.33
UPSIDE:
30.75%
Stock News
Fluor Corporation (NYSE:FLR) Stock Has Average Price Target of $63.33
Shares of Fluor Corporation (NYSE: FLR - Get Free Report) have received a consensus rating of "Hold" from the eight ratings firms that are presently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and four have given a buy rating to the
XRP Drops 51% in a Year Despite New Ways to Earn Yield—Will It Impact the Price?
XRP holders keep getting new ways to earn yield on their coins, yet the price keeps falling anyway. Whether the latest vault partnership from Doppler and Flare can finally break that pattern depends on details neither company has revealed yet.
Fluor Corporation to Hold Third Quarter Earnings Conference Call
IRVING, Texas--(BUSINESS WIRE)--Fluor Corporation (NYSE: FLR) will hold a conference call to review results for its third quarter ended September 30, 2026. The public is invited to listen to the conference call on Friday, November 6, 2026, at 8:30 a.m. Eastern with Chief Executive Officer Jim Breuer and Chief Financial Officer John Regan. Financial results will be released prior to the market open that day. The live webcast and a reply will be available with accompanying slides online at invest.
Fluor-JGC JV Selected for LNG Canada Phase 2 Expansion Project
FLR's JGC joint venture will execute LNG Canada Phase 2, with Fluor set to recognize a $7.5 billion share as production capacity is poised to double.
Shell Greenlights LNG Canada Phase 2, Doubling Export Capacity
SHEL greenlights LNG Canada Phase 2, doubling capacity to 28 mtpa and securing nearly 6 mtpa of additional LNG from the project.
Fluor Joint Venture Selected for LNG Canada Phase 2 Expansion Following Final Investment Decision
[url="]Fluor Corporation[/url] (NYSE: FLR) announced today that its joint venture with JGC Corporation has been selected to deliver engineering, procurement, fa
New Industry Survey Reinforces Nuclear's Growth Outlook
The owners and operators of commercial reactors in the U.S. are planning for a larger and longer-lasting fleet. A recent survey of utility companies from the Nuclear Energy Institute (NEI) highlights rising interest in new reactors and expectations for operating lives beyond 80 years.
Are Construction Stocks Lagging Fluor (FLR) This Year?
Here is how Fluor (FLR) and Owens Corning (OC) have performed compared to their sector so far this year.
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and deserve attention.
Hsbc Holdings PLC Acquires 22,500 Shares of Fluor Corporation $FLR
Hsbc Holdings PLC raised its position in Fluor Corporation (NYSE: FLR) by 57.4% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 61,671 shares of the construction company's stock after purchasing an additional 22,500 shares during the quarter. Hsbc Holdings PLC's holdings
(PODCAST) Voyageur Pharmaceuticals (TSXV:VM) Achieves First Milestone in Bayer Collaboration, Secures USD $1 Million Payment
CALGARY, Alberta — September 10 , 2026 — Leads & Copy — Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (OTC Pink: VYYRF), a Canadian company focused on developing pharmaceutical-grade barium and iodine contrast media for medical imaging, has achieved its first milestone under a non-dilutive Collaboration and Funding Agreement with Bayer AG. The company announced that it successfully submitted a complete feasibility work plan and timetable, which has been approved by Bayer. The milestone achievement triggers the first major non-dilutive payment of USD $1,000,000 from Bayer. This payment, combined with the initial USD $350,000 received on March 31, 2026, brings the total funding received by Voyageur from Bayer to USD $1,350,000 of the committed USD $2,350,000.
Voyageur Pharmaceuticals Achieves First Milestone on Feasibility Study for Iodine Production; Secures USD $1 Million Payment
CALGARY, Alberta – TheNewswire - September 9, 2026 – Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (OTC Pink: VYYRF) (“ Voyageur ” or the “ Company ”), a Canadian developer of pharmaceutical-grade barium and iodine contrast media for medical imaging, is pleased to announce that it has achieved the first milestone under its non-dilutive Collaboration and Funding Agreement with Bayer AG (“ Bayer ”) dated February 10, 2026 (the “ Agreement ”) by submitting a complete feasibility work plan and timetable which has been approved by Bayer. (Collaboration funding news https://finance.yahoo.com/news/voyageur-pharmaceuticals-announces-collaboration-bayer-144926270.html )
Construction Firms Powering the Nuclear Renaissance
Investors usually focus on reactor developers and uranium miners when deciding on allocations for investing in the nuclear renaissance. A narrow view on the nuclear sector could result in missed opportunities for investment returns in nuclear-adjacent companies.
Is Fluor (FLR) Stock Outpacing Its Construction Peers This Year?
Here is how Fluor (FLR) and James Hardie (JHX) have performed compared to their sector so far this year.
Nuclear Energy Scaling Up Through New Federal Projects
Two of the most significant government-led nuclear energy programs are illustrating how quickly the advanced nuclear field is expanding. The Nuclear Energy Launch Pad added 13 reactor and fuel cycle technology projects to its development pipeline.
Algert Global LLC Has $7.57 Million Stock Holdings in Fluor Corporation $FLR
Algert Global LLC lifted its position in Fluor Corporation (NYSE: FLR) by 14.4% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 144,400 shares of the construction company's stock after buying an additional 18,190 shares during the period.
Fluor Corp.: The Turnaround Is Gaining Traction, But Execution Remains The Test
Fluor Corporation is executing a multi-year turnaround, shifting to reimbursable contracts and leveraging AI to improve project execution and margins. FLR's $27B backlog is nearly 4x its $7.3B market cap, with 85% now reimbursable, reducing legacy fixed-price risk and enhancing earnings visibility. Management's modernization, AI-driven project controls, and focus on high-demand sectors—nuclear, data centers, and defense—increase FLR's strategic positioning.
DOE Backs X-Energy Texas Reactor Project With $1 Billion Support
The U.S. Department of Energy (DOE) has given X-Energy (XE) up to $1 billion in additional public funding support for its high-temperature gas-cooled reactor project in Texas. The funding marks another significant federal commitment to advancing next-generation nuclear power generation to meet growing electricity demands.
Fluor Corp (FLR) Shares Fall 3.5% -- What GF Score of 74 Tells Investors
On August 20, 2026, Fluor Corp (FLR) shares fell 3.5% to $52.16, trading within a 52-week range of $39.33 to $57.93. The decline today reflects a broader concer
Price Targets
Fluor price target raised to $71 from $64 at Truist
$71.00
(was $53.69)
Jamie Cook
·
Truist Financial
Fluor price target raised to $66 from $59 at UBS
$66.00
(was $54.61)
Steven Fisher
·
UBS
Fluor price target raised to $50 from $40 at Barclays
$50.00
(was $57.00)
Adam Seiden
·
Barclays
Fluor price target raised to $64 from $57 at Truist
$64.00
(was $50.35)
Truist Financial
Fluor (FLR) PT Raised to $60 at DA Davidson: 'Constructive on Medium/Long Term Opportunities'
$60.00
(was $53.29)
Brent Thielman
·
D.A. Davidson
Fluor price target raised to $59 from $56 at Truist
$59.00
(was $51.40)
Jamie Cook
·
Truist Financial
Fluor price target raised to $57 from $52 at UBS
$57.00
(was $51.62)
UBS
Fluor price target raised to $48 from $45 at Baird
$48.00
(was $48.57)
Robert W. Baird
Fluor price target raised to $56 from $51 at Truist
$56.00
(was $44.65)
Truist Financial
Fluor price target lowered to $51 from $52 at Truist
$51.00
(was $42.71)
Truist Financial
Fluor price target lowered to $52 from $59 at Truist
$52.00
(was $39.99)
Truist Financial
Fluor price target raised to $60 from $48 at UBS
$60.00
(was $51.24)
Steven Fisher
·
UBS
Fluor price target lowered to $41 from $43 at Baird
$41.00
(was $34.42)
Andrew Wittmann
·
Robert W. Baird
Fluor price target lowered to $41 from $54 at KeyBanc
$41.00
(was $31.02)
Sangita Jain
·
KeyBanc
Fluor price target lowered to $40 from $45 at Barclays
$40.00
(was $37.77)
Barclays
Fluor downgraded to Neutral from Outperform at Baird
$58.00
(was $50.11)
Andrew Wittmann
·
Robert W. Baird
Citi Upgrades Fluor (FLR) to Buy
$65.00
(was $53.86)
Andrew Kaplowitz
·
Citigroup
Fluor price target raised to $66 from $61 at Truist
$66.00
(was $50.43)
Jamie Cook
·
Truist Financial
Fluor price target raised to $61 from $54 at Truist
$61.00
(was $44.26)
Jamie Cook
·
Truist Financial
Fluor (FLR) PT Raised to $58 at DA Davidson
$58.00
(was $45.63)
Brent Thielman
·
D.A. Davidson